These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31830258)

  • 21. Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on left ventricular mass index and ejection fraction in hemodialysis patients: A meta-analysis with trial sequential analysis of randomized controlled trials.
    Yang Y; Wang R; Li MX; Xing Y; Li WG
    Int J Cardiol; 2016 Sep; 219():350-7. PubMed ID: 27352206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effects of Cholecalciferol Supplementation on FGF23 and α-Klotho in Hemodialysis Patients With Hypovitaminosis D: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Etemadi J; Samadifar M; Ghojazadeh M; Motavalli R; Oriyo R; Majidi T; Tayebi Khosroshahi H
    J Ren Nutr; 2022 May; 32(3):334-340. PubMed ID: 34294550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Vitamin D Supplementation on Kidney Function in Adults with Prediabetes: A Secondary Analysis of a Randomized Trial.
    Kim SH; Brodsky IG; Chatterjee R; Kashyap SR; Knowler WC; Liao E; Nelson J; Pratley R; Rasouli N; Vickery EM; Sarnak M; Pittas AG; ;
    Clin J Am Soc Nephrol; 2021 Aug; 16(8):1201-1209. PubMed ID: 34362787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.
    Chung EY; Ruospo M; Natale P; Bolignano D; Navaneethan SD; Palmer SC; Strippoli GF
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD007004. PubMed ID: 33107592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does Vitamin D Provide Added Benefit to Antihypertensive Therapy in Reducing Left Ventricular Hypertrophy Determined by Cardiac Magnetic Resonance?
    Levy PD; Twiner MJ; Brody AM; Dawood R; Reed B; Mango L; Gowland L; Grandits G; Svendsen K; Haacke EM; Li T; Zhang L; McNaughton CD; Flack JM
    Am J Hypertens; 2023 Jan; 36(1):50-62. PubMed ID: 36008108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial.
    Wang AY; Fang F; Chan J; Wen YY; Qing S; Chan IH; Lo G; Lai KN; Lo WK; Lam CW; Yu CM
    J Am Soc Nephrol; 2014 Jan; 25(1):175-86. PubMed ID: 24052631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D supplementation and prevention of cardiovascular disease and cancer in the Finnish Vitamin D Trial: a randomized controlled trial.
    Virtanen JK; Nurmi T; Aro A; Bertone-Johnson ER; Hyppönen E; Kröger H; Lamberg-Allardt C; Manson JE; Mursu J; Mäntyselkä P; Suominen S; Uusitupa M; Voutilainen A; Tuomainen TP; Hantunen S
    Am J Clin Nutr; 2022 May; 115(5):1300-1310. PubMed ID: 34982819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of vitamin D on endothelial and ventricular function in chronic heart failure patients: A prospective, randomized, placebo-controlled trial.
    Woo JS; Woo Y; Jang JY; Ha SJ
    Medicine (Baltimore); 2022 Jul; 101(29):e29623. PubMed ID: 35866799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D.
    Marckmann P; Agerskov H; Thineshkumar S; Bladbjerg EM; Sidelmann JJ; Jespersen J; Nybo M; Rasmussen LM; Hansen D; Scholze A
    Nephrol Dial Transplant; 2012 Sep; 27(9):3523-31. PubMed ID: 22822092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular effects of cholecalciferol treatment in dialysis patients--a randomized controlled trial.
    Mose FH; Vase H; Larsen T; Kancir AS; Kosierkiewic R; Jonczy B; Hansen AB; Oczachowska-Kulik AE; Thomsen IM; Bech JN; Pedersen EB
    BMC Nephrol; 2014 Mar; 15():50. PubMed ID: 24661355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.
    Thadhani R; Appelbaum E; Pritchett Y; Chang Y; Wenger J; Tamez H; Bhan I; Agarwal R; Zoccali C; Wanner C; Lloyd-Jones D; Cannata J; Thompson BT; Andress D; Zhang W; Packham D; Singh B; Zehnder D; Shah A; Pachika A; Manning WJ; Solomon SD
    JAMA; 2012 Feb; 307(7):674-84. PubMed ID: 22337679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D supplementation for sickle cell disease.
    Soe HHK; Abas AB; Than NN; Ni H; Singh J; Said ARBM; Osunkwo I
    Cochrane Database Syst Rev; 2020 May; 5(5):CD010858. PubMed ID: 32462740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of vitamin D deficiency and effects of supplementation with cholecalciferol in patients with chronic kidney disease.
    Kim SM; Choi HJ; Lee JP; Kim DK; Oh YK; Kim YS; Lim CS
    J Ren Nutr; 2014 Jan; 24(1):20-5. PubMed ID: 24216258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria.
    Susantitaphong P; Nakwan S; Peerapornratana S; Tiranathanagul K; Katavetin P; Srisawat N; Praditpornsilpa K; Eiam-Ong S
    BMC Nephrol; 2017 Jan; 18(1):19. PubMed ID: 28088187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Vitamin D3 Versus Placebo on Cardiac Structure and Function: A Randomized Clinical Trial.
    Chandra A; Picard MH; Huang S; Gupta DK; Agusala K; Buring JE; Lee IM; Cook NR; Manson JE; Thadhani RI; Wang TJ
    J Am Heart Assoc; 2022 Nov; 11(21):e025008. PubMed ID: 36285795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized double-blind placebo-controlled trial of vitamin D supplementation in juvenile-onset systemic lupus erythematosus: positive effect on trabecular microarchitecture using HR-pQCT.
    Lima GL; Paupitz JA; Aikawa NE; Alvarenga JC; Pereira RMR
    Osteoporos Int; 2018 Mar; 29(3):587-594. PubMed ID: 29152675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Vitamin D on Cardiac Function in Patients With Chronic HF: The VINDICATE Study.
    Witte KK; Byrom R; Gierula J; Paton MF; Jamil HA; Lowry JE; Gillott RG; Barnes SA; Chumun H; Kearney LC; Greenwood JP; Plein S; Law GR; Pavitt S; Barth JH; Cubbon RM; Kearney MT
    J Am Coll Cardiol; 2016 Jun; 67(22):2593-603. PubMed ID: 27058906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insight into the impact of vitamin D on cardiovascular outcomes in chronic kidney disease.
    Junarta J; Jha V; Banerjee D
    Nephrology (Carlton); 2019 Aug; 24(8):781-790. PubMed ID: 30684283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermittent cholecalciferol supplementation in children and teenagers followed in pediatric nephrology: data from a prospective single-center single-arm open trial.
    Aurelle M; Basmaison O; Ranchin B; Kassai-Koupai B; Sellier-Leclerc AL; Bertholet-Thomas A; Bacchetta J
    Eur J Pediatr; 2020 Apr; 179(4):661-669. PubMed ID: 31873802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.